Keppra vs. Lamictal

Summary

We compare the side effects and drug effectiveness of Keppra and Lamictal. The study is created by eHealthMe based on reports of 166,312 people who take Keppra and Lamictal, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on levetiracetam and lamotrigine (the active ingredients of Keppra and Lamictal, respectively), and Keppra and Lamictal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 46,892 users)

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. (latest outcomes from Lamictal 64,115 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 09, 2019

166,312 people who take Keppra and Lamictal are studied.


Number of reports submitted per year:

Keppra vs Lamictal drug comparison reports.

Drugs in this study:

  • Keppra (levetiracetam)
  • Lamictal (lamotrigine)

eHealthMe real world results:

Most common side effects:

Keppra:
  1. Rash
  2. Drug Ineffective
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Pyrexia (fever)
  5. Nausea (feeling of having an urge to vomit)
  6. Headache (pain in head)
  7. Dizziness
  8. Fatigue (feeling of tiredness)
  9. Depression
  10. Vomiting
Lamictal:
  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Drug Ineffective
  3. Fatigue (feeling of tiredness)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Headache (pain in head)
  6. Nausea (feeling of having an urge to vomit)
  7. Fall
  8. Dizziness
  9. Vomiting
  10. Pyrexia (fever)

Most common side effects experienced by people in long term use:

Keppra:
  1. Rash
  2. Depression
  3. Drug Ineffective
  4. Anxiety
  5. Dizziness
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Headache (pain in head)
  10. Insomnia (sleeplessness)
Lamictal:
  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Depression
  3. Dizziness
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  6. Insomnia (sleeplessness)
  7. Drug Ineffective
  8. Fatigue (feeling of tiredness)
  9. Abnormal Behaviour
  10. Fall

Drug effectiveness:

Keppra:
  • not at all: 3.46 %
  • somewhat: 18.16 %
  • moderate: 30.72 %
  • high: 31.25 %
  • very high: 16.41 %
Lamictal:
  • not at all: 4.16 %
  • somewhat: 14.37 %
  • moderate: 23.94 %
  • high: 34.53 %
  • very high: 23.0 %

Do you take Keppra or Lamictal?

You are not alone:




Related publications that referenced our studies

Related studies:



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!